Recall Record

Franklin Lakes, NJ, United States

Becton Dickinson & Company recalls

96 recalls recorded since 2018, most recently on 13 August 2026. 36 are listed as ongoing. Status and classification are as published by the FDA.

Recalls96
Ongoing (FDA)36
Terminated or completed60
Class I (FDA)4

Ongoing Class II Medical devices

Recall started
13 August 2026
Reason
Potential for quality control failures with Klebsiella pneumoniae ATCC BAA-1705 when using the CPO Ambler classification feature.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0139-2027, Z-0140-2027

Ongoing Class II Medical devices

Recall started
11 August 2026
Reason
Due to incorrect switching of Channel 1 and 2 on the module and flag labels on the tissue oximetry cables.
Distribution
Worldwide - U.S Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY. The country of Grand Cayman.
Initiated
Voluntary: Firm initiated
Recall number
Z-3250-2026

Ongoing Class I Medical devices

Recall started
27 April 2026
Reason
This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
Distribution
Nationwide distribution to AK, AL, AR, AZ, CA, CO, CT, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, MS, NC, NE, NH, NJ, NV, NY, OH, OR, PA, PR, SD, TN, TX, UT, VA, WA, WI, WV, WY.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2251-2026, Z-2250-2026, Z-2257-2026, Z-2255-2026, Z-2249-2026, Z-2253-2026, Z-2254-2026, Z-2248-2026, Z-2252-2026, Z-2256-2026

Ongoing Class II Medical devices

Recall started
8 April 2026
Reason
Catheters may, due to a manufacturing process and material changes, leak/break from the (blue) proximal injectate lumen hub, which may lead to infection, medication loss, and/or blood loss.
Distribution
Worldwide - US Nationwide distribution including in the states of TX, SC, CT, GA, VA, MO, NM, UT, NJ, CA, FL, PA, IN, TN, WA, KY, MD, WV, MI, MA, NC, MN, NY, AZ, AL, LA, CO, OK, HI, MS, IL, OH, NE, DC, KS, NV, WI, SD, IA, AR, ID, OR, WY, MT, RI, VT, DE, AK, NH, ND, ME, PR and the countries of Japan,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2203-2026, Z-2204-2026, Z-2202-2026

Ongoing Class II Medical devices

Recall started
7 April 2026
Reason
BD identified an issue affecting certain lots of BD GasPak EZ CO2 and BD GasPak EZ Campy Gas Generating Pouch Systems, where gas generating sachets may produce carbon dioxide levels below specification.
Distribution
Worldwide distribution - US Nationwide and the country of Hong Kong.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1982-2026, Z-1983-2026

Ongoing Class II Medical devices

Recall started
27 January 2026
Reason
During the bulk packaging process, some Luer Slip syringes were incorrectly included in a batch designated for Luer Lok syringes.
Distribution
US Nationwide distribution in the states of California and Texas.
Initiated
Voluntary: Firm initiated
Recall number
Z-1496-2026

Ongoing Class II Medical devices

Recall started
23 October 2025
Reason
The 2D barcodes on these cuvettes contain formatting errors that prevent the analyzing system from correctly reading the expiration date. As a result, the instrument enters an error state and the cuvettes cannot be used.
Distribution
Worldwide - US Nationwide distribution in the states of CO, CT, KY, NJ, TN, TX, UT and the countries of Belgium, Singapore, Taiwan, Germany, Switzerland.
Initiated
Voluntary: Firm initiated
Recall number
Z-0484-2026

Ongoing Class II Medical devices

Recall started
14 October 2025
Reason
BD has confirmed through internal testing that certain device trays failed routine biocompatibility testing.
Distribution
Worldwide - US Nationwide distribution including in the states of AL, AZ, CA, CO, FL, GA, HI, IA, ID, IL, IN, LA, MA, MD, MI, MN, MO, MS, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, SD, TN, TX, UT, VA, WA, WI, WV and the countries of Canada, Singapore, Hong Kong.
Initiated
Voluntary: Firm initiated
Recall number
Z-0504-2026

Ongoing Class II Medical devices

Recall started
23 September 2025
Reason
Product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
Distribution
Worldwide distribution. US Nationwide including Guam and Puerto Rico, Algeria, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahrain, Bangladesh, Belarus, Belgium, Bosnia and Herzegovina, Botswana, Brazil, Bulgaria, Burkina Faso, Burundi, Cambodia, Canada, Chile, China, Colombia, Costa Rica,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0235-2026, Z-0237-2026, Z-0240-2026, Z-0236-2026, Z-0238-2026, Z-0239-2026

Ongoing Class II Medical devices

Recall started
23 June 2025
Reason
Potential for functionality issue that supports the Over labeling feature and could lead to possible false negative results.
Distribution
Worldwide - US Nationwide distribution in the states of Florida, Texas and Michigan. The countries of Sweden and Belgium.
Initiated
Voluntary: Firm initiated
Recall number
Z-2162-2025

Ongoing Class II Medical devices

Recall started
20 May 2025
Reason
BD has received additional complaints of intermittent false resistance results for PZA during susceptibility testing of Mycobacterium tuberculosis isolates.
Distribution
Worldwide distribution - US Nationwide and the countries of AR, AU, BD, BE, BN, BR, CA, CN, CR, DO, GT, HK, HT, ID, IN, JP, KH, KR, MO, MX, MY, NP, NZ, PE, PH, PK, SG, SV, TH, TW, VN.
Initiated
Voluntary: Firm initiated
Recall number
Z-2023-2025

Ongoing Class II Medical devices

Recall started
12 February 2025
Reason
One component of the kit was shipped with an expiration date of 30Sep2024 while the Certificate of Analysis (COA) indicated an expiration date of 30Apr2025.
Distribution
Domestic: AZ, CA, CO, GA, KY, IL, IN, NC, NJ, NY, MA, MD, TX, WA. International: Singapore, New Zealand, Chile, Australia, Taiwan, Malaysia.
Initiated
Voluntary: Firm initiated
Recall number
Z-1296-2025

Ongoing Class II Medical devices

Recall started
19 December 2024
Reason
Potential for signal drift in specific lots of BD PCR Cartridges.
Distribution
Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DC, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, TN, TX, UT, VA, VT, WA, WI, WV, WY and the countries of Canada, South Korea, T
Initiated
Voluntary: Firm initiated
Recall number
Z-1004-2025

Ongoing Class II Medical devices

Recall started
6 November 2024
Reason
BD identified through potency testing as part of a stability test request to monitor Ampicillin AM-2 due to decrease in potency results of 65% at 18 months, may result in falsely resistant result for ampicillin susceptibility
Distribution
Worldwide - US Nationwide distribution in the states of CA, GA, IL, KY, MA, MD, NE, PA and the countries of Canada, Belgium, Singapore, Malaysia.
Initiated
Voluntary: Firm initiated
Recall number
Z-0621-2025

Ongoing Class II Medical devices

Recall started
31 October 2024
Reason
BD confirmed that product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
Distribution
Worldwide distribution - US Nationwide and the countries of Algeria, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahrain, Bangladesh, Belarus, Belgium, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Chile
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0589-2025, Z-0591-2025, Z-0590-2025, Z-0593-2025, Z-0584-2025, Z-0586-2025, Z-0596-2025, Z-0588-2025, Z-0585-2025, Z-0587-2025, Z-0594-2025, Z-0595-2025 and 1 more

Ongoing Class II Medical devices

Recall started
12 September 2024
Reason
Synapsys software versions 4.20, 4.30, 5.10, 5.20, or 5.30 and utilizing the in-line breakpoint feature, an error is occurring where BD Synapsys will incorrectly display breakpoints for organisms that do not have defined breakpoints in CLSI or EUCAST. This occurs when the identified organism is included in the same interpretive group as a species for which there is a specific breakpoint. May result in either a false susceptible or false resistant result. A false susceptible result can cause inadequate or incomplete antibiotic treatment due to the use of an ineffective antibiotic, and a false resistant result may limit access to a preferred antibiotic regimen with possible elongation of therapy
Distribution
Nationwide Foreign: Australia, New Zealand, Singapore, Hong Kong, Taiwan, Japan, Austria, Belgium, Denmark, France, Germany, Italy, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom, Russia, Saudi Arabia, South Africa, Canada, Mexico, China
Initiated
Voluntary: Firm initiated
Recall number
Z-0026-2025

Ongoing Class II Medical devices

Recall started
1 August 2024
Reason
Escherichia coli (E. coli) misidentification for clinical samples that were tested on BD Phoenix" M50 instrument and BD Phoenix" 100, may lead to misdiagnosis and inappropriate treatment of infections caused by E. coli,
Distribution
Worldwide distribution - US Nationwide and the countries of Algeria, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Bulgaria, Burkina Faso, Burundi, Cambodia, Canada, Cayman Islands, Chile, China, Colombia
Initiated
Voluntary: Firm initiated
Recall numbers
Z-3246-2024, Z-3247-2024

Ongoing Class II Medical devices

Recall started
18 July 2024
Reason
May intermittently produce falsely resistant results for pyrazinamide (PZA) during susceptibility testing of Mycobacterium tuberculosis isolates.
Distribution
Worldwide distribution - US Nationwide and the countries of Argentina, Australia, Bangladesh, Belgium, Brunei, Brazil, Canada, China, Costa Rica, Dominican Republic, Guatemala, Guyana, Hong Kong, Haiti, Indonesia, India, Japan, Korea, Myanmar, Macau, Mexico, Malaysia, Nepal, New Zealand, Panama, Per
Initiated
Voluntary: Firm initiated
Recall number
Z-2686-2024

Ongoing Class II Medical devices

Recall started
9 July 2024
Reason
There is a potential risk that the image colony count does not adequately reflect the actual plate colony count and may lead to inaccurate counts that would impact patient diagnosis and subsequent care.
Distribution
US distribution to states of: CO, CT, IA, IL, KY, MD, MI, MN, NC, NJ, NY, OH, OK, SC, TN, TX and WA.
Initiated
Voluntary: Firm initiated
Recall number
Z-2585-2024

Ongoing Class II Medical devices

Recall started
7 May 2024
Reason
Assays may produce false negative results due to decreased activity of the enzyme utilized in manufacturing.
Distribution
Domestic: Nationwide Distribution; Foreign: AU, BR, BE, CA, CO, & JP.
Initiated
Voluntary: Firm initiated
Recall number
Z-2023-2024

Ongoing Class II Medical devices

Recall started
29 February 2024
Reason
Esculin, a substrate used in other panels and normally in A16 well, was found in A17 well. A17 in yeast panels is supposed to be an empty well and is not a part of the normal ID evaluation. However, A17 is checked for fluorescence and if anything is found, the system will abort the panel with the message Fluorescent interference has been detected. Esculin is expected to trigger this fluorescence and test cancellation.
Distribution
Worldwide distribution - US Nationwide and the countries of AR, BE, CO, IN, JP, PE, PY, SG, TW, UY.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1399-2024, Z-1398-2024

Ongoing Class II Medical devices

Recall started
8 January 2024
Reason
There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
Distribution
Domestic distribution nationwide. International distribution worldwide.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1037-2024, Z-1015-2024, Z-1038-2024, Z-1021-2024, Z-1011-2024, Z-1034-2024, Z-1017-2024, Z-1020-2024, Z-1040-2024, Z-1033-2024, Z-1022-2024, Z-1018-2024 and 18 more

Ongoing Class II Medical devices

Recall started
16 November 2023
Reason
An incorrect stopper was used in nine lots of 10mL BD PosiFlush Normal Saline Flush Syringes with General Pump Compatibility. The use of BD PosiFlush Prefilled Flush Syringes with this stopper causes an increase in injection force, which has the potential to trigger alarms if used with a syringe pump.
Distribution
US Nationwide distribution including in the states of AL, AZ, CA, CO, FL, GA, HI, IA, IL, IN, KS, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NM, NY, OH, OK, OR, PA, SC, SD, TN, TX,UT, VA, WA, WI, WV.
Initiated
Voluntary: Firm initiated
Recall number
Z-0736-2024

Ongoing Class II Medical devices

Recall started
11 October 2023
Reason
Affected infusion sets labeled as free of DEHP actually do contain di(2-ethylhexyl) phthalate (DEHP).
Distribution
Worldwide - US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WI, WY, Puerto Rico, Guam; and the cou
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0350-2024, Z-0351-2024, Z-0349-2024

Ongoing Class II Medical devices

Recall started
12 September 2023
Reason
Certain vials of the BD BACTEC" Plus Aerobic/F Culture Vials have a labeling issue where duplicate barcode sequence numbers have been identified on more than one vial.
Distribution
Worldwide - US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-0110-2024

Ongoing Class II Medical devices

Recall started
8 June 2023
Reason
There is a risk of mis-association of patient demographic data for users who choose to report results manually when their Service Control Unit (SCU) is operating near capacity and are using save actions (Skip, Final Discard, Mark as Read, Save) to process patient results rapidly.
Distribution
US States: CA, CO, IA, IL, MI, MN, MO, NY, OH, OK, SC, TN, TX, UT, WI. Australia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Japan, Luxembourg, Netherlands, New Zealand, Norway, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, United Kingdom
Initiated
Voluntary: Firm initiated
Recall number
Z-2099-2023

Ongoing Class II Medical devices

Recall started
1 May 2023
Reason
IFU- Instructions for Use (IFU) package insert and both the IFU packaged with the test kit and the electronic version on the BD website not approved by FDA,specifically describing specimen type, could cause use of the test with invalid specimen types, which may produce false positive or false negative results.Erroneous results can cause a delay in diagnosis or treatment
Distribution
Worldwide distribution - US Nationwide and the countries of CA, CL, HK, TW.
Initiated
Voluntary: Firm initiated
Recall number
Z-1682-2023

Ongoing Class II Medical devices

Recall started
22 March 2023
Reason
Upon installation of BD Kiestra" InoqulA+" and BeA version 5.1 and 5.1.1 as part of the Icefall A platform, plate information was not visible in Synapsys" after processing has occurred. This could possibly lead to a delayed diagnosis and/or treatment or need for specimen recollection streaking plated media, and inoculating tubes and slides. In Semi-Automated (SA) mode, plates are automatically selected, barcoded, streaked in a pre-configured pattern while the user manually inoculates plates, tubes, and slides. An optional biosafety cabinet on the SA module provides personnel, product, and environmental protection. The InoqulA+" solution is indicated for use in the clinical laboratory.
Distribution
Worldwide - US Nationwide distribution in the states of IL, NY and the countries of Netherlands, Saudi Arabia.
Initiated
Voluntary: Firm initiated
Recall number
Z-1415-2023

Ongoing Class II Medical devices

Recall started
1 February 2023
Reason
Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.
Distribution
Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Mexico, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, Canada.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1240-2023, Z-1242-2023, Z-1237-2023, Z-1244-2023, Z-1239-2023, Z-1243-2023, Z-1241-2023, Z-1238-2023

Ongoing Class II Medical devices

Recall started
21 November 2022
Reason
Boxes contain a reduced concentration of Nicotinamide Adenine Dinucleotide and does not provide enough of the blood factors necessary to support Haemophilus growth. The reduction could cause a false negative result for Haemophilus isolation in a clinical specimen.
Distribution
Worldwide distribution - US Nationwide and the countries of Canada, India, Philippines.
Initiated
Voluntary: Firm initiated
Recall number
Z-0473-2023

Ongoing Class II Medical devices

Recall started
13 October 2022
Reason
Misformulated minocycline-can cause erroneously increased Minimal Inhibitory Concentration (MIC) values when performing antibiotic susceptibility testing (AST) against minocycline and result in the reporting of false resistance for clinical samples if the initial Quality Control (QC) testing of the panel batch passes, delaying treatment of the patient with the most appropriate antibiotic
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-0232-2023

Ongoing Class II Medical devices

Recall started
15 September 2022
Reason
The affected product contains isobutylene which has recently demonstrated potential interference in determination of methanol by gas chromatography methods. The interference may lead to false positive results in methanol testing.
Distribution
Distribution US nationwide, Canada, New Zealand, and Hong Kong.
Initiated
Voluntary: Firm initiated
Recall number
Z-0095-2023

Ongoing Class II Medical devices

Recall started
18 July 2022
Reason
Incorrect expiration date listed on the product labels. The expiration date listed on the product label is beyond the expiration date of the product.
Distribution
US Nationwide Distribution CA FL GA IL MD MI OR PA PR TN TX
Initiated
Voluntary: Firm initiated
Recall number
Z-1555-2022

Ongoing Class II Medical devices

Recall started
9 May 2022
Reason
May have the potential for leakage at the housing component of the stopcock, may result in delay or interruption in treatment, exposure to infusate and biohazardous material, under dosing/under infusion, contamination and/or air ingress.
Distribution
Worldwide distribution - US Nationwide distribution in the states of AK, AR, AZ, CA, CO, FL, GA, IL, IN, KS, MA, MD, MI, MN, MO, MS, NC, NE, NJ, NV, NY, OH, OR, PA, SD, TN, TX, UT, VA, WA, WV and the countries of Belgium, China, India, Indonesia, Japan, Korea, Nepal, Philippines, Singapore, Sri Lank
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1433-2022, Z-1432-2022, Z-1440-2022, Z-1438-2022, Z-1434-2022, Z-1441-2022, Z-1437-2022, Z-1439-2022, Z-1435-2022, Z-1436-2022, Z-1431-2022

Terminated Class II Medical devices

Recall started
9 March 2022
Terminated
19 January 2024
Reason
When updating BD Kiestra customers to BD Synapsys version 4.10, the custom antibiotic codes set by the customer are overwritten with the BD default antibiotic codes.
Distribution
Worldwide distribution US Nationwide distribution in the states of CA, IL, MI, NY, OH, SC, and TN. The countries of Austria, France, Germany, Netherlands, Sweden.
Initiated
Voluntary: Firm initiated
Recall number
Z-1018-2022

Ongoing Class III Medical devices

Recall started
6 January 2022
Reason
May shed contaminant particles into the urine specimen that may be misidentified as Red Blood Cells when used in conjunction with the Sysmex UF-1000i or UX-2000 Analyzers and lead to false elevations in RBC counts
Distribution
US Nationwide distribution in the state of IL.
Initiated
Voluntary: Firm initiated
Recall number
Z-0665-2022

Ongoing Class II Medical devices

Recall started
5 January 2022
Reason
May have the potential to overheat and/or cause fire, the issue can occur when an unauthorized alternative AC power adapter, and not the one provided by BD is used to power the instrument.
Distribution
Worldwide distribution - US Nationwide and the countries of Armenia, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Dominican Republic, Ecuador, Fiji, Guatemala, Hong Kong, Honduras, Haiti, Indonesia, India, Jamaica, Cambodia, South Korea, Macao, Mexico, New Zealand, Panama, Peru, Phili
Initiated
Voluntary: Firm initiated
Recall number
Z-0630-2022

Terminated Class II Medical devices

Recall started
27 September 2021
Terminated
4 May 2023
Reason
Holes in product packaging impacts package integrity and may compromise sterility.
Distribution
TX
Initiated
Voluntary: Firm initiated
Recall number
Z-0179-2022

Terminated Class II Medical devices

Recall started
24 March 2021
Terminated
2 August 2022
Reason
BioGX SARS-CoV-2 Reagents for BD MAX" System rehydration buffer tubes were not adequately sealed causing some tubes to be partially filled or empty upon use. A partially filled or empty rehydration buffer tube may lead to an Unresolved (UNR) result on the BD MAX" System
Distribution
US Nationwide
Initiated
Voluntary: Firm initiated
Recall number
Z-1416-2021

Terminated Class II Medical devices

Recall started
17 March 2021
Terminated
5 August 2022
Reason
Products show heavy growth of C. albicans after 24 hours of incubation due to misformulation (expected reaction is partial inhibition after 18-48 hours incubation) and reduce the identification of Neisseria contributing to a delay in time to definitive diagnosis or a delay in proper treatment
Distribution
Worldwide distribution - US Nationwide distribution and the countries of Canada, Korea.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1377-2021, Z-1378-2021

Terminated Class II Medical devices

Recall started
7 January 2021
Terminated
3 December 2021
Reason
Some N1 and N2 master mix pouches packaged within the lots of BioGX SARS-CoV-2 Reagents for BD MAX System may be mislabeled. This could result in a kit containing two pouches of N1 master mix or two pouches of N2 master mix, instead of one pouch of each. If laboratory personnel do not notice that both pouches contain tubes with the same color foil seal and use two of the same tubes, there is a low potential for a false negative SARS-CoV-2 result. A false negative SARS-CoV-2 result could lead to an increased risk of disease progression for the patient and additional spread of SARS-CoV-2 if the patient is not quarantined.
Distribution
US nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-0954-2021

Terminated Class II Medical devices

Recall started
23 December 2020
Terminated
21 November 2022
Reason
The product packaging for the 10 ml eccentric tip syringe may exhibit open seals. An open seal impacts package integrity and potentially compromises sterility of the syringe.
Distribution
Distribution US nationwide and Canada
Initiated
Voluntary: Firm initiated
Recall number
Z-1109-2021

Terminated Class II Medical devices

Recall started
9 December 2020
Terminated
10 August 2022
Reason
BD was advised by the European Notified Body, NSAI, that the instructions for use (IFU) needs to be updated to include the general contraindications
Distribution
Alabama, Connecticut, Florida, Illinois, Indiana, Michigan, Missouri, Mississippi, North Carolina, Nebraska, Nevada, New York, Pennsylvania, Rhode Island, Tennessee, Texas, Utah, Virginia. Foreign: Australia, Canada, Belgium and Singapore
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0924-2021, Z-0923-2021

Terminated Class II Medical devices

Recall started
8 December 2020
Terminated
3 October 2023
Reason
BD Phoenix Sulfamethoxazole-trimethoprim (SXT) Resistance, false resistant SXT result with S. aureus could lead to a potential loss of access to a preferred antibiotic regimen and potential reduction in effectiveness of treatment of the infection
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0761-2021, Z-0762-2021, Z-0763-2021, Z-0765-2021, Z-0759-2021, Z-0764-2021, Z-0760-2021, Z-0766-2021

Terminated Class II Medical devices

Recall started
18 November 2020
Terminated
15 February 2024
Reason
BD has confirmed the presence of blood on the cannulas of the BD PrecisionGlide needles 30G X 1/2" Lot No. 9128897. The possibility of infection may be present if the blood is not noticed prior to use by the clinician.
Distribution
Worldwide distribution - US Nationwide distribution including in the states of CA, CT, FL, IL, KY, MO, NJ, NY, OH, PA, PR, SC, TN, VA and the countries of Canada, China, Singapore.
Initiated
Voluntary: Firm initiated
Recall number
Z-0588-2021

Terminated Class II Medical devices

Recall started
23 October 2020
Terminated
8 September 2023
Reason
Product shelf cartons incorrectly labeled as products intended for the Latin American market. Although the product description on the label 32G x 4mm pen needles is correct, information pertinent to users in the US regarding compatibility with specific pen needles is missing.
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall number
Z-0508-2021

Terminated Class II Medical devices

Recall started
14 September 2020
Terminated
27 September 2021
Reason
Dull/blunt needles within the IV Catheter System may lead to missed insertion attempts and delay in diagnosis or treatment until a new needle is inserted
Distribution
US: Nationwide Distribution: AK, AR, AZ, CA, IL, KS, MO, NY, OH, UT, VA; and International to: Canada and Mexico.
Initiated
Voluntary: Firm initiated
Recall number
Z-0125-2021

Terminated Class II Medical devices

Recall started
14 September 2020
Terminated
9 November 2021
Reason
Kits do not contain the stylet/T-lock assembly indicated as a component on the label, may lead to a procedural delay and possibly discard of the kit.
Distribution
Foreign: Italy, Spain, and UK
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0295-2021, Z-0294-2021

Terminated Class II Medical devices

Recall started
28 July 2020
Terminated
23 April 2021
Reason
Printed scale markings on the 3mL SafetyGlide syringes, with catalog # 305924, Lot# 8289599, are printed incorrectly. The scale is skewed to different degrees, resulting in missing and/or partially printed scale numbers and scale lines.
Distribution
US and Canada
Initiated
Voluntary: Firm initiated
Recall number
Z-2889-2020

Terminated Class II Medical devices

Recall started
20 July 2020
Terminated
13 July 2021
Reason
BD is experiencing elevated rates of potential false positive results from certain customers when using the BD SARS-CoV-2 Reagents for the BD MAX System. False positive test results could lead to a delay in diagnosis and potentially cause the patient to be exposed to COVID-19 if they are isolated with an infected individual.
Distribution
Worldwide distribution - US Nationwide distribution including in the states of AZ, CA, CO, DC, FL, GU, HI, IL, IN, KY, MD, MI, MO, NC, NJ, NY, PA, SC, TN, TX, WI, WY and the countries of Argentina, Australia, Belgium, Brazil, Canada, Chile, Colombia, Hong Kong, Japan, Mexico, New Zealand, Peru, Ph
Initiated
Voluntary: Firm initiated
Recall number
Z-2754-2020

Terminated Class II Medical devices

Recall started
19 June 2020
Terminated
29 July 2022
Reason
Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A crack or break could result in potential blood loss, catheter occlusion, air embolism, under or interrupted infusion, or site contamination which could lead to infection.
Distribution
Worldwide Distribution
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2662-2020, Z-2667-2020, Z-2670-2020, Z-2668-2020, Z-2666-2020, Z-2661-2020, Z-2660-2020, Z-2669-2020, Z-2665-2020, Z-2664-2020, Z-2663-2020, Z-2671-2020

Terminated Class II Medical devices

Recall started
16 April 2020
Terminated
1 September 2021
Reason
This product has been confirmed to exhibit holes in the packaging, which impacts package integrity and potentially compromises a sterile field.
Distribution
Nationwide domestic distribution. Foreign distribution to Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK, Australia, Canada, Mexico, Malaysia, New Zealand
Initiated
Voluntary: Firm initiated
Recall number
Z-2065-2020

Terminated Class II Medical devices

Recall started
14 April 2020
Terminated
10 February 2022
Reason
May exhibit increased levels of artifacts which could be difficult to distinguish from gram positive cocci, increased levels of artifacts could result in a false-positive Gram stain
Distribution
Worldwide distribution - US Nationwide distribution and the countries of Canada, Taiwan, Hong Kong, Chile, EMEA, Thailand, China, Japan, Australia, New Zealand, Korea, Costa Rica, Mexico, Canada, and Singapore.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2046-2020, Z-2047-2020, Z-2048-2020

Terminated Class II Medical devices

Recall started
26 March 2020
Terminated
21 August 2020
Reason
The 8 Fr catheter was manufactured with the 6.9 Fr needle instead of the 8 Fr needle.
Distribution
Domestic distribution to the following states: Alabama, Colorado, Illinois, Massachusetts, Missouri, Oklahoma, Rhode Island, Virginia, and Wisconsin.
Initiated
Voluntary: Firm initiated
Recall number
Z-1795-2020

Terminated Class II Medical devices

Recall started
17 March 2020
Terminated
21 October 2020
Reason
Iincorrectly packaged without the required lidocaine as labeled
Distribution
AZ, CT, GA, IL, LA, MA, MI, MN, ND, NE, NY, OH, SD, TX),
Initiated
Voluntary: Firm initiated
Recall number
Z-1946-2020

Terminated Class II Medical devices

Recall started
26 February 2020
Terminated
22 September 2020
Reason
The kits contain surgical gowns which were subject to a recall by the supplier.
Distribution
The products were distributed to the following US states: IN, MO, OH, and TX.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2078-2020, Z-2082-2020, Z-2076-2020, Z-2077-2020, Z-2079-2020, Z-2081-2020, Z-2075-2020, Z-2080-2020

Terminated Class II Medical devices

Recall started
4 November 2019
Terminated
19 November 2020
Reason
The indicator may show available charge when the battery is close to depletion. As a result, the Site~Rite 8 has the potential to abruptly shut down, without advance warning to the user, when running on battery power only
Distribution
Nationwide Foreign: UK, Belgium, Australia, Japan, Canada, Taiwan, Colombia, Chile, Philippines, Thailand, Brazil, Hong Kong, Chile, Argentina, Mexico, India, Singapore
Initiated
Voluntary: Firm initiated
Recall number
Z-0518-2020

Terminated Class II Medical devices

Recall started
14 October 2019
Terminated
16 October 2020
Reason
Limited number of syringes labeled Posiflush Experimental Product and Not for Human Use being mixed with standard BD Posiflush Pre-Filled Normal Saline Syringes.
Distribution
Distribution US Nationwide and Canada
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0500-2020, Z-0499-2020

Terminated Class II Medical devices

Recall started
16 September 2019
Terminated
29 June 2020
Reason
A portion of the lot was incorrectly packaged with a 12.5cm catheter instead of a 15cm catheter.
Distribution
Distributed to healthcare facilities in AR, FL, IL, NJ, TX, and WI.
Initiated
Voluntary: Firm initiated
Recall number
Z-0285-2020

Terminated Class II Medical devices

Recall started
1 August 2019
Terminated
6 May 2020
Reason
Product Pouches may not be sealed properly and compromise the sterility of the device
Distribution
CA, IL Foreign: Taiwan
Initiated
Voluntary: Firm initiated
Recall number
Z-2411-2019

Terminated Class II Medical devices

Recall started
31 July 2019
Terminated
27 July 2020
Reason
Separation of front and rear barrels upon activation of the safety feature that retracts the needle
Distribution
Worldwide distribution - US Nationwide distribution including the states of CT, FL, MO, TN, OH, TX, GA, NC, SC, IN, IL, PA, CO and countries of Trinidad and Tobago, Hong Kong.
Initiated
Voluntary: Firm initiated
Recall number
Z-0193-2020

Terminated Class II Medical devices

Recall started
26 July 2019
Terminated
6 December 2019
Reason
An anomaly is present in InoqulA / InoqulA+ software version 20.3, has the potential to cause a mismatch between a specimen and plate
Distribution
Illinois, Iowa, Missouri, New York, Ohio, Tennessee World Wide (5): Singapore, Taiwan, France, Netherlands
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2439-2019, Z-2438-2019

Terminated Class II Medical devices

Recall started
17 July 2019
Terminated
13 May 2020
Reason
The foil bags containing extraction tubes for BD MAX" Reagent products may not been sealed properly.
Distribution
AL, AR, AZ, CA, CO, CT, FL, GA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MT, NC, NH, NJ, NM, NV, NY, OH, OR, PA, PR, RI, SC, TN, TX, VA, WA, WI, WV Worldwide: Australia, Belgium, Brazil, Canada, Chile, China, Hong Kong, Japan, Korea, Mexico, Singapore, Taiwan
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2337-2019, Z-2332-2019, Z-2323-2019, Z-2338-2019, Z-2321-2019, Z-2339-2019, Z-2327-2019, Z-2324-2019, Z-2328-2019, Z-2336-2019, Z-2326-2019, Z-2333-2019 and 7 more

Terminated Class II Medical devices

Recall started
12 June 2019
Terminated
29 June 2020
Reason
False elevation of carboxyhemoglobin (COHb) results have been reported when using venous blood gas samples collected with tubes analyzed with the IL GEM 4000 instrument.
Distribution
Worldwide Distribution, including US Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2300-2019, Z-2301-2019, Z-2305-2019, Z-2296-2019, Z-2308-2019, Z-2297-2019, Z-2307-2019, Z-2303-2019, Z-2309-2019, Z-2299-2019, Z-2310-2019, Z-2306-2019 and 3 more

Terminated Class II Medical devices

Recall started
3 June 2019
Terminated
8 December 2020
Reason
The products have been confirmed to have reduced or no additive within the tube reservoir. The tubes may develop visible clots within the tube samples or micro clots that are not easily detected during visual inspection of the tubes. A clotted sample may lead to recollection of samples or, retesting of patients, resulting in delayed reporting of test results and patient treatment.
Distribution
The products were distributed to the following US states: AL, CA, CT, FL, GA, IL, KY, MD, MN, MO, OH, PA, TN, TX, VA, and Puerto Rico.
Initiated
Voluntary: Firm initiated
Recall number
Z-1967-2019

Terminated Class II Medical devices

Recall started
30 May 2019
Terminated
5 May 2020
Reason
Lot has been confirmed to have no additive within the tube. Sample processed without the preservative (additive) in the tube, testing has yielded reliable results if the samples were stored at room temperature for no longer than two days. If the sample was stored for more than 2 days, the result for blood alcohol determination might not be accurate (either falsely low or falsely high)
Distribution
US Nationwide-Distribution in the states of CA, FL, GA, IL, KS, MO, PA, RI, TN Foreign: Canada
Initiated
Voluntary: Firm initiated
Recall number
Z-2279-2019

Terminated Class II Medical devices

Recall started
13 May 2019
Terminated
6 August 2020
Reason
Damaged reservoir may lead to a decreased fill volume causing samples to be insufficient for testing and improper blood-to-additive ratio, potentially producing erroneous results.
Distribution
Nationwide Foreign: AR AU BE BN BR CA CL CN CO CR CW EC GT GY HK HN ID IN JP KR MX MY NI NZ PA PE PG PH PK SG SR SV TH TW UY VN
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0059-2020, Z-0058-2020, Z-0056-2020, Z-0060-2020, Z-0054-2020, Z-0055-2020, Z-0061-2020, Z-0057-2020

Terminated Class I Medical devices

Recall started
6 May 2019
Terminated
19 July 2021
Reason
An incomplete occlusion can be caused by a variation in the wall thickness of the pumping segment of the affected infusion sets used with the. The issue has the potential to lead to unintended delivery of medication when the pump module is not in running status or can result in faster than expected drug delivery flow when the pump is infusing.
Distribution
Worldwide Distribution; US (nationwide distribution) to following US states: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, GU, HI, IA, IL, ID, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MP, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, VA, VT, WA, WI, WV, WY, and Puerto Rico
Initiated
Voluntary: Firm initiated
Recall number
Z-1770-2019

Terminated Class II Medical devices

Recall started
2 May 2019
Terminated
30 November 2021
Reason
After disconnection of a luer, the valve of the connector remains recessed; not fully closing, either temporarily or permanently. The risks of blood loss and air embolism exist if the valve remains permanently open and goes undetected, especially in the neonate population.
Distribution
Nationwide Foreign: Canada
Initiated
Voluntary: Firm initiated
Recall number
Z-0049-2020

Terminated Class II Medical devices

Recall started
10 April 2019
Terminated
22 December 2020
Reason
BD has decided to initiate a voluntary recall due to a confirmed complaint trend for droplets of fluid separating from the sealed surface of the MaxZero connector, following disconnection.
Distribution
Nationwide domestic distribution. Foreign distribution to Argentina Australia Austria Belgium Brazil Canada Chile China Colombia Croatia Cyprus Czech Republic Denmark Finland France Germany Hungary India Italy Japan Jordan Kuwait Lebanon Mexico Morocco Netherlands Norway O
Initiated
Voluntary: Firm initiated
Recall number
Z-0284-2020

Terminated Class II Medical devices

Recall started
3 April 2019
Terminated
4 May 2020
Reason
Background calibration has the potential to cause false positive or false negative test results. An incorrect test result with the BD Veritor System could lead to possible misdiagnosis and inappropriate treatment
Distribution
Nationwide Foreign: Canada, Chile, Hong Kong, Japan, Taiwan
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1314-2019, Z-1313-2019

Terminated Class II Medical devices

Recall started
7 March 2019
Terminated
12 May 2020
Reason
The luer could break and cause the device to leak or break off and get stuck in the fistula needle port rendering the port inaccessible for dialysis. As a result, the patient would need to be re-cannulated with a new fistula needle to obtain their dialysis treatment.
Distribution
US distribution to the states of FL and NJ.
Initiated
Voluntary: Firm initiated
Recall number
Z-1122-2019

Terminated Class II Medical devices

Recall started
7 March 2019
Terminated
11 February 2022
Reason
BD PAS received customer complaints indicating the absence of the bevel on the non-patient needle end of the product, causing blood leakage.
Distribution
Distributed to accounts in AR, CT, FL, IL, IN, MI, MO, MS, NY, OH, TN, TX, and VA. Foreign distribution to Canada, Brazil, India, Mexico, Singapore, and Taiwan.
Initiated
Voluntary: Firm initiated
Recall number
Z-0252-2020

Terminated Class II Medical devices

Recall started
5 March 2019
Terminated
15 July 2020
Reason
The firm has initiated a recall due to a confirmed complaint trend for kinked tubing on the specified lots of the product.
Distribution
Distributed to accounts in AL, CA, DC, FL, LA, MD, NE, TN, VA, and WA.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1121-2019, Z-1120-2019

Terminated Class II Medical devices

Recall started
1 March 2019
Terminated
21 May 2020
Reason
Leak from the septum assembly or the canister may burst under high pressure which could result in blood exposure to a health care worker.
Distribution
US distribution to one distributor in VA.
Initiated
Voluntary: Firm initiated
Recall number
Z-1710-2019

Terminated Class I Medical devices

Recall started
28 February 2019
Terminated
30 July 2020
Reason
Leaking of the Smartsite Syringe Administration Set. May result in delay or interruption of infusion, under-infusion, contamination of the fluid path and HCP exposure to infusates.
Distribution
US Nationwide Distribution in the states of AR, NH, NC
Initiated
Voluntary: Firm initiated
Recall number
Z-1210-2019

Terminated Class II Medical devices

Recall started
21 February 2019
Terminated
17 April 2020
Reason
BD Synapsys version 2.1 allowed the potential for a test order to be associated to an incorrect culture record.
Distribution
Worldwide Distribution - US: Nationwide in the states of OH, IL, MO, TN and the countries of Netherlands
Initiated
Voluntary: Firm initiated
Recall number
Z-1051-2019

Terminated Class II Medical devices

Recall started
1 February 2019
Terminated
11 June 2020
Reason
The syringes have scale markings that were printed incorrectly. The scale is skewed to varying degrees, resulting in missing and/or partially printed scale numbers and scale lines.
Distribution
The products were distributed to the following US states: FL, IL, KS, MA, ND, NH, NY, OH, PA, RI, SC, VA, and WI. The products were distributed to the following foreign countries: Suriname.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2007-2019, Z-2008-2019

Terminated Class II Medical devices

Recall started
14 January 2019
Terminated
3 April 2020
Reason
False negative results with the BD MAX Extended Enteric Bacterial Panel when testing specifically for Enterotoxigenic Escherichia coli (ETEC) and Plesiomonas shigelloides targets of the BD MAX Extended Enteric Bacterial Panel assay.
Distribution
Worldwide Distribution: US (nationwide) to states of:CA, GA, HI, ID, MI, MN, MT, NJ, NM, OH, OR, PA, SC, TX, VA, VT, WA ; and to countries of: Australia, New Zealand, Canada, Europe, and Korea.
Initiated
Voluntary: Firm initiated
Recall number
Z-0981-2019

Terminated Class II Medical devices

Recall started
20 December 2018
Terminated
10 April 2020
Reason
Panels inoculated using certain lots of the indicator solution are demonstrating an increased occurrence of test aborts.
Distribution
The products were distributed to the following US states: AL, AR, AZ, CA, CO, CT, DC, FL, GA, IA, ID, IL, IN, KS, KY, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, WV, and WY. The products were distributed to the following foreign countries:
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0934-2019, Z-0935-2019, Z-0933-2019

Terminated Class II Medical devices

Recall started
22 October 2018
Terminated
3 April 2020
Reason
a portion of a single lot was not manufactured in accordance with the internal formulation resulting in inhibited growth of Gram negative organisms.
Distribution
US Nationwide distribution in the states of AL, AR, AZ, CA, CT, FL, GA, HI, MA, MD, MI, MN, NC, NH, NJ, NY, OH, OK, PA, RI, TX, VA, VT, WA, WV
Initiated
Voluntary: Firm initiated
Recall number
Z-0528-2019

Terminated Class II Medical devices

Recall started
26 September 2018
Terminated
13 April 2020
Reason
The products have the potential to leak between the connection of the male luer lock and the yellow striped tubing.
Distribution
Worldwide Distribution - US Nationwide in the states of: AK, AL, AR, AZ, CA, CO, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MD, ME, MI, MO, MT, NC, NE, NJ, NV, NY, OH, OR, PA, SC, TN, TX, UT, VA, WA, WI, WV, and Guam. The products were distributed to the following foreign countries: Canada, United
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0387-2019, Z-0386-2019

Terminated Class II Medical devices

Recall started
24 September 2018
Terminated
10 April 2020
Reason
A trend for false positive Candida glabrata results has been confirmed. The discrepant results impact the Candida glabrata target only, when in the presence of a Trichomonas vaginalis true positive.
Distribution
Worldwide distribution - US nationwide in the states of AL, AZ, CA, CO, DC, FL, GA, IL, IN, KY, LA, MD, MI, MO, NC, NJ, NM, NY, OH, OR, PA, SC, TN, TX, UT, VA, WA, WI, and Puerto Rico. Countries of Spain, Germany, France, Austria, Denmark, Switzerland, Sweden, Italy, Kuwait, Oman, Saudi Arabia, and
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0313-2019, Z-0312-2019

Terminated Class III Medical devices

Recall started
21 September 2018
Terminated
25 April 2019
Reason
The device may not function at the lower end (<15 deg. C) of the labeled operating temperatures. The instrument returns to normal operating conditions when environmental temperatures are at or above 15 deg. C. This issue has no potential to cause harm to either the patient or the operator. At the lower temperature, the instrument may fail to initialize, in which case slides would require manual screening. Therefore, no slides are screened by the device and no results can be released in error. The instrument labeling has been revised to indicate an operating temperature lower limit of 18 deg. C and operating humidity of 20 to 80% relative humidity.
Distribution
Worldwide distribution: US (Nationwide) and to countries of: Korea, Australia, Japan, Malaysia, Canada, Brazil, and Belgium.
Initiated
Voluntary: Firm initiated
Recall number
Z-0081-2019

Terminated Class II Medical devices

Recall started
30 August 2018
Terminated
21 October 2020
Reason
BD Vacutainer Urine Collection Cups may contribute to a slight elevation of Red Blood Cell (RBC) counts when used with the Sysmex UF Series Analyzers. BD recommends following Good Clinical Practice (GCP) by using microscopy to confirm an elevated RBC Count in a Urine sample as per CLSI GP16-3A. 29(4) and CAP Checklist on Urinalysis. Product will continue to ship to not impact critical patient care.
Distribution
Illinois
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0491-2019, Z-0494-2019, Z-0493-2019, Z-0492-2019

Terminated Class II Medical devices

Recall started
23 August 2018
Terminated
28 February 2020
Reason
One lot of the specified needles is not performing as intended due to a failure in the needle tip shield/safety mechanism, which may lead to an increased risk of a contaminated needlestick injury.
Distribution
Worldwide Distribution -US Nationwide in the states of: CA, CO, FL, GA, IL, LA, MI, ND, NE, NY, OH, PA, RI, SC, VA, WA and WV. The products were distributed to the following foreign countries: Argentina, Australia, Belgium, Brazil, Canada, Colombia, Costa Rica, Mexico and New Zealand.
Initiated
Voluntary: Firm initiated
Recall number
Z-0384-2019

Terminated Class II Medical devices

Recall started
21 June 2018
Terminated
9 July 2019
Reason
A portion of this lot was manufactured using Gentamicin instead of Vancomycin. Gentamicin is an inhibitory agent of Neisseria organisms. This product is a selective plated medium to provide enhanced growth and recovery of N gonorrhoeae. Inhibited growth may cause a false negative result or a delayed result leading to incorrect or delayed treatment.
Distribution
US Distribution in states of: AK, AL, AR, AZ, CA, CO, DC, DE, FL, GA, HI, ID, IN, KS, KY, MA, MI, MS, MT, NC, JH, NY, OK, OR, PA, SC, TN, TX, WA, and WI.
Initiated
Voluntary: Firm initiated
Recall number
Z-2869-2018

Terminated Class II Medical devices

Recall started
11 April 2018
Terminated
10 May 2019
Reason
Approximately 3.4% of BD Vacutainer Plus Plastic Citrate Blood Collection Tubes (2.7mL) (light blue top tube) will exhibit over fill draw volumes from ~11-14%.
Distribution
US/PR-All 50 states and PR Global-AR, BO, BR, BS, BZ, CA, CO, CR, CW, DO, EC, GT, GY, IN, JM, JP, KR, MX, NI, PA, PE, SG, SR, SV, TT, TW, UY, VI Dates of distribution: June 2, 2017 to the present.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2260-2018, Z-2258-2018, Z-2259-2018

Terminated Class I Medical devices

Recall started
22 March 2018
Terminated
25 July 2022
Reason
BD Vacutainer EDTA Lavender, Tan, and Pink Top Tubes and BD Vacutainer Lithium Heparin Green Top Tubes can cause an underestimation of lead in blood samples when used with Magellan Diagnostics LeadCare assays, employing the Anodic Stripping Voltammetry (ASV) methodology, or any other assay employing ASV methodology.
Distribution
Distributed in 46 states: AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MT, NC, ND, NE, NH, NJ, NM, NY, NV, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, and Puerto Rico.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1142-2018, Z-1141-2018, Z-1140-2018, Z-1139-2018

Terminated Class II Medical devices

Recall started
20 March 2018
Terminated
20 April 2020
Reason
Products do not meet the labeled sterility claim of a Sterility Assurance Level (SAL) 10-6.
Distribution
US (Nationwide) Canada, Kuwait, Guyana, Guatemala, Taiwan, UK, Belgium, Sweden, Ireland, Israel, Spain, Switzerland and Lithuania
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1533-2018, Z-1532-2018, Z-1531-2018

Terminated Class III Medical devices

Recall started
2 March 2018
Terminated
2 July 2018
Reason
The package insert incorrectly lists the volume of the primer and probe diluent to use for the reconstitution of the master mix tube. Adding the incorrect amount of diluent could have an effect on the assay.
Distribution
Distributed to accounts in 8 states: CA, FL, NJ, NY, OR, PA, VA, and WI. International distribution to Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Europe, Hong Kong, Japan, Singapore, Taiwan, and Thailand.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1544-2018, Z-1545-2018

Terminated Class II Medical devices

Recall started
13 February 2018
Terminated
9 March 2020
Reason
Tubes may exhibit stopper creepout/pullout, where the stopper dissociates from the tube
Distribution
US Nationwide, Argentina, Belize , Brazil, Canada, China, Guam, India, Japan, Mexico, Nicaragua, Pakistan, Philippines, Singapore, Suriname, Taiwan
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2056-2018, Z-2055-2018

Terminated Class II Medical devices

Recall started
3 October 2017
Terminated
9 October 2018
Reason
HighPuragar was mislabeled and inadvertently sold as Noble Agar.
Distribution
USA (nationwide) Distribution to the states of and including Puerto Rico : AL, AZ, CA, FL, GA, IA, IL, IN, LA, MA, MD, ME, MI, MN, MO, MT, NC, NE, NJ, NY, OH, OR, PA,TN, TX, UT, VA, WA
Initiated
Voluntary: Firm initiated
Recall number
Z-0935-2018

Terminated Class II Medical devices

Recall started
18 September 2017
Terminated
4 February 2019
Reason
Increased amount of residual blood present on the top of stopper well after venipuncture
Distribution
USA (nationwide)
Initiated
Voluntary: Firm initiated
Recall number
Z-1180-2018

Terminated Class II Medical devices

Recall started
29 August 2017
Terminated
16 May 2019
Reason
A limited portion of the lot was manufactured with less than the required amount of K2EDTA additive, an anticoagulant, which may cause erroneous results that could lead to specimen recollection and potential delay of treatment or misdiagnosis/mismanagement of treatment and serious complications, such as failure to detect thrombocytosis or postponing surgery.
Distribution
Nationwide Distribution
Initiated
Voluntary: Firm initiated
Recall number
Z-0968-2018

Terminated Class II Medical devices

Recall started
18 July 2017
Terminated
9 July 2018
Reason
BD recently notified customers in July 2017 regarding an increased rate of unresolved (UNR) and indeterminate (IND) results for the BD MAXTM Vaginal Panel, experienced by some customers. A non-reportable result may lead to repeat of the test and/or re-collection of a specimen.
Distribution
US and OUS.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0392-2018, Z-0393-2018, Z-0394-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.